Prognostic and predictive value of clinical and biochemical factors in breast cancer patients with bone metastases receiving "metronomic" zoledronic acid

被引：0
|
作者：
Xinmin Zhao
Xiaofeng Xu
Qunling Zhang
Zhen Jia
Si Sun
Jian Zhang
Biyun Wang
Zhonghua Wang
Xichun Hu
机构：
[1] Fudan University,Department of Medical Oncology, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College
[2] Fudan University,Department of Clinical Laboratory, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College
来源：
BMC Cancer | / 11卷
关键词：
Advanced breast cancer; bone metastases; zoledronic acid; VEGF; N-telopeptide; prognosis; predictive factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Randomized trial of denosumab versus zoledronic acid in prostate cancer patients with bone metastases and elevated bone turnover markers after receiving zoledronic acid therapy
    Bosserman, Linda
    Fizazi, Karim
    Lipton, Allan
    Rahim, Yasmin
    Suarez, Tirzo
    Fan, Michelle
    Wu, Ling
    Markus, Richard A.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 335 - 336
  • [22] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
    不详
    BREAST, 2005, 14 : S45 - S46
  • [23] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
    Rosen, L.
    Gordon, D.
    Chen, Y. M.
    CANCER TREATMENT REVIEWS, 2006, 32 : S43 - S43
  • [24] Zoledronic acid and survival in breast cancer patients with bone Metastases and elevated markers of osteoclast activity
    Lipton, Allan
    Cook, Richard J.
    Major, Pierre
    Smith, Matthew R.
    Coleman, Robert E.
    ONCOLOGIST, 2007, 12 (09): : 1035 - 1043
  • [25] Long-term safety of zoledronic acid for the treatment of patients with breast cancer and bone metastases
    Lipton, A.
    Dewar, R.
    Conte, R.
    Zheng, M.
    EJC SUPPLEMENTS, 2004, 2 (03): : 142 - 142
  • [26] Cost-Effectiveness of Denosumab Compared With Zoledronic Acid in Patients With Breast Cancer and Bone Metastases
    Xie, Jipan
    Diener, Melissa
    Sorg, Rachael
    Wu, Eric Q.
    Namjoshi, Madhav
    CLINICAL BREAST CANCER, 2012, 12 (04) : 247 - 258
  • [27] Proven efficacy of zoledronic acid in the treatment of bone metastases in patients with breast cancer and other malignancies
    Cameron, D
    BREAST, 2003, 12 : S22 - S29
  • [28] Continuing benefit of zoledronic acid for the prevention of skeletal complications in breast cancer patients with bone metastases
    不详
    BREAST, 2005, 14 : S44 - S44
  • [29] Effect of zoledronic acid on serum angiogenic factors in patients with bone metastases
    Tas, Faruk
    Duranyildiz, Derya
    Oguz, Hilal
    Camlica, Hakan
    Yasasever, Vildan
    Topuz, Erkan
    MEDICAL ONCOLOGY, 2008, 25 (03) : 346 - 349
  • [30] Prognostic Factors in Patients with Metastatic Breast Cancer with Bone-Only Metastases
    Parkes, Amanda
    Warneke, Carla L.
    Clifton, Katherine
    Al-Awadhi, Aydah
    Oke, Oluchi
    Pestana, Roberto Carmagnani
    Alhalabi, Omar
    Litton, Jennifer K.
    Hortobagyi, Gabriel N.
    ONCOLOGIST, 2018, 23 (11): : 1282 - 1288
12345